Pdl Biopharma, Inc. - Net Worth and Insider Trading
Pdl Biopharma, Inc. Net Worth
The estimated net worth of Pdl Biopharma, Inc. is at least $92 dollars as of 2024-11-13. Pdl Biopharma, Inc. is the 10% Owner of Evofem Biosciences Inc and owns about 7,111 shares of Evofem Biosciences Inc (EVFM) stock worth over $92. Details can be seen in Pdl Biopharma, Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Pdl Biopharma, Inc. has not made any transactions after 2019-06-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Pdl Biopharma, Inc.
Pdl Biopharma, Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Pdl Biopharma, Inc. owns 2 companies in total, including LENSAR Inc (LNSR) , and Evofem Biosciences Inc (EVFM) .
Click here to see the complete history of Pdl Biopharma, Inc.’s form 4 insider trades.
Insider Ownership Summary of Pdl Biopharma, Inc.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LNSR | LENSAR Inc | 2020-09-17 | 10 percent owner |
| EVFM | Evofem Biosciences Inc | 2019-06-10 | 10 percent owner |
Pdl Biopharma, Inc. Latest Holdings Summary
Pdl Biopharma, Inc. currently owns a total of 1 stock. Pdl Biopharma, Inc. owns 7,111 shares of Evofem Biosciences Inc (EVFM) as of June 10, 2019, with a value of $92.
Latest Holdings of Pdl Biopharma, Inc.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EVFM | Evofem Biosciences Inc | 2019-06-10 | 7,111 | 0.01 | 92 |
Holding Weightings of Pdl Biopharma, Inc.
Pdl Biopharma, Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, Pdl Biopharma, Inc. has made a total of 0 transactions in Evofem Biosciences Inc (EVFM) over the past 5 years. The most-recent trade in Evofem Biosciences Inc is the acquisition of 3,556 shares on June 10, 2019, which cost Pdl Biopharma, Inc. around $30 Million.
Insider Trading History of Pdl Biopharma, Inc.
- 1
Pdl Biopharma, Inc. Trading Performance
GuruFocus tracks the stock performance after each of Pdl Biopharma, Inc.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Pdl Biopharma, Inc. is -20.13%. GuruFocus also compares Pdl Biopharma, Inc.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Pdl Biopharma, Inc. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Pdl Biopharma, Inc.'s insider trading performs compared to the benchmark.
Performance of Pdl Biopharma, Inc.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -21.38 | | | | | |
| Relative Return to S&P 500(%) | -25.06 | | | | | |
Pdl Biopharma, Inc. Ownership Network
Ownership Network List of Pdl Biopharma, Inc.
Ownership Network Relation of Pdl Biopharma, Inc.
Pdl Biopharma, Inc. Owned Company Details
What does LENSAR Inc do?
Who are the key executives at LENSAR Inc?
Pdl Biopharma, Inc. is the 10 percent owner of LENSAR Inc. Other key executives at LENSAR Inc include 10 percent owner North Run Capital, Lp , 10 percent owner North Run Advisors, Llc , and director & 10 percent owner Thomas B Ellis .
LENSAR Inc (LNSR) Insider Trades Summary
Over the past 18 months, Pdl Biopharma, Inc. made no insider transaction in LENSAR Inc (LNSR). Other recent insider transactions involving LENSAR Inc (LNSR) include a net purchase of 10,000 shares made by Gary M Winer , and a net purchase of 50,000 shares made by Aimee S Weisner .
In summary, during the past 3 months, insiders sold 0 shares of LENSAR Inc (LNSR) in total and bought 5,495 shares, with a net purchase of 5,495 shares. During the past 18 months, 0 shares of LENSAR Inc (LNSR) were sold and 60,000 shares were bought by its insiders, resulting in a net purchase of 60,000 shares.
LENSAR Inc (LNSR)'s detailed insider trading history can be found in Insider Trading Tracker table.
LENSAR Inc Insider Transactions
Pdl Biopharma, Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for Pdl Biopharma, Inc.. You might contact Pdl Biopharma, Inc. via mailing address: 59 Damonte Ranch Parkway, Suite B-375, Reno Nv 89521.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
